Abstract:Plants belonging to the Oxytropis genus, family Leguminosae, are found throughout the world, with about 80 species mainly distributed in northwest and northeast China. The plants have medicinal properties and many plants have been used as folk medicine for the treatment of colds, inflammation of carbuncle swelling, pain, and different types of bleeding. In recent years, due to the reduced availability of wild resources and increased clinical demand, additional Oxytropis species have been used in Mongolian medicine. This study explored the medicinal potential of four Oxytropis species, investigating their phylogeny, chemical components, and pharmacological activities. Oxytropis myriophylla (Pall) DC., Oxytropis hirta Bunge, and Oxytropis bicolor Bge. were found to be closely related at the taxonomic level. While previous investigations on the bioactive constituents of Oxytropis have been limited and have concentrated largely on flavonoids and saponins, the present study established a novel UHPLC-Q-TOF/MS based on metabolite profiling to comprehensively analyze the chemical composition of the four Oxytropis species and to identify marker compounds. A total of 75 compounds were identified from the four species, with 23 identified as characteristic marker components. Twenty-six marker compounds were identified in O. myriophylla from different geographical regions. Analysis of pharmacological activity showed that extracts of O. myriophylla and O. hirta had stronger anti-inflammatory activity than the extracts from the other species. The relationships between the chemical components, traditional curative uses, and pharmacological activities were analyzed to provide a preliminary documentation of the pharmacophylogenetic characteristics of the Oxytropis family as a whole. Several marker compounds, including licoricesaponin G2, licoricesaponin J2, and glycyrrhizic acid found in O. hirta were found to have effective anti-inflammatory activity, consistent with the traditional application of reducing swelling and healing wounds. This preliminary investigation into the pharmacophylogeny of the genus Oxytropis will contribute to the conservation and exploitation of the medicinal resources of this genus.

Seven undescribed compounds from dried flower buds of Ochrocarpus longifolius

A new coumarin and a new flavonoid from Ochrocarpus longifolius

Alkaloids from Oxytropis Ochrocephala Bunge

Hypoglycemic oligostilbenes from the stems of Caragana sinica

Three New Compounds from Oxyria Digyna (L.) Hill

8-<i>O</i>-<i></i>-D-Glucopyranosyl-2-methylchromone, a new chromone glycoside from the Tibetan medicine plant of<i>Swertia punicea</i>Hemsl

[Heterocyclic compounds and phenolic glycosides from flowers of Dendrobium officinale]

Chemical Constituents in Roots of Osbeckia Opipara.

Two new triterpenoids from the carpophore of Xanthoceras sorbifolia Bunge.

Three New Compounds from Morus Nigra L.

Screening of metabolic markers present in Oxytropis by UHPLC-Q-TOF/MS and preliminary pharmacophylogenetic investigation

Carbohydrates from Cynanchum Otophyllum.

[Phenylethanoid glycosides from stem of Chirita longgangensis var. hongyao]

Liposoluble chemical constituents from the fibrous root of Ophiopogon japonicas

Seven undescribed compounds from the flower heads of Helianthus annuus L.

Carboxymethyl Flavonoids and a Monoterpene Glucoside from Selaginella Moellendorffii.

Glucoconjugated Monoterpene Indole Alkaloids from Uncaria Rhynchophylla

Seven new 3,4-dihydro-furanocoumarin derivatives from Angelica dahurica

A New Chalcone from the Heartwood of Dalbergia Cochinchinensis

A New Oxoaporphine from Desmos chinensis Lour.

A New Flavonol from Oxytropis Ochrocephala Bunge